These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24254496)

  • 1. Inference for the median residual life function in sequential multiple assignment randomized trials.
    Kidwell KM; Ko JH; Wahed AS
    Stat Med; 2014 Apr; 33(9):1503-13. PubMed ID: 24254496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cox regression methods for two-stage randomization designs.
    Lokhnygina Y; Helterbrand JD
    Biometrics; 2007 Jun; 63(2):422-8. PubMed ID: 17425633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.
    Li Z
    Stat Med; 2017 Feb; 36(3):403-415. PubMed ID: 27646957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted Kaplan-Meier estimators for two-stage treatment regimes.
    Miyahara S; Wahed AS
    Stat Med; 2010 Nov; 29(25):2581-91. PubMed ID: 20799259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data.
    Pullenayegum EM; Willan AR
    Stat Med; 2007 Jul; 26(17):3274-99. PubMed ID: 17309112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to estimate the variance of an endpoint from an on-going blinded trial.
    Xing B; Ganju J
    Stat Med; 2005 Jun; 24(12):1807-14. PubMed ID: 15803440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.
    Wahed AS; Tsiatis AA
    Biometrics; 2004 Mar; 60(1):124-33. PubMed ID: 15032782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.
    Austin PC
    Stat Med; 2016 Dec; 35(30):5642-5655. PubMed ID: 27549016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth bootstrap methods for analysis of longitudinal data.
    Li Y; Wang YG
    Stat Med; 2008 Mar; 27(7):937-53. PubMed ID: 17701950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-sample adjustments in using the sandwich variance estimator in generalized estimating equations.
    Pan W; Wall MM
    Stat Med; 2002 May; 21(10):1429-41. PubMed ID: 12185894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim monitoring of sequential multiple assignment randomized trials using partial information.
    Manschot C; Laber E; Davidian M
    Biometrics; 2023 Dec; 79(4):2881-2894. PubMed ID: 36896962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On Variance of the Treatment Effect in the Treated When Estimated by Inverse Probability Weighting.
    Reifeis SA; Hudgens MG
    Am J Epidemiol; 2022 May; 191(6):1092-1097. PubMed ID: 35106534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study.
    Young JG; Vatsa R; Murray EJ; Hernán MA
    Trials; 2019 Sep; 20(1):552. PubMed ID: 31488202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the Relation Between G-formula and Inverse Probability Weighting Estimators for Generalizing Trial Results.
    Dahabreh IJ; Robertson SE; Hernán MA
    Epidemiology; 2019 Nov; 30(6):807-812. PubMed ID: 31517670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A note on variance estimation in random effects meta-regression.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2005; 15(5):823-38. PubMed ID: 16078388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations.
    NeCamp T; Kilbourne A; Almirall D
    Stat Methods Med Res; 2017 Aug; 26(4):1572-1589. PubMed ID: 28627310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.